Minerva Neurosciences, Inc (NERV) is a publicly traded Healthcare sector company. As of August 7, 2026, NERV trades at $4.44 with a market cap of $202.66M and a P/E ratio of -0.13. NERV moved +2.07% today. Year to date, NERV is +13.27%; over the trailing twelve months it is +145.86%. Its 52-week range spans $1.15 to $12.46. Analyst consensus is neutral with an average price target of $7.00. Rallies surfaces NERV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for NERV, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $4.44 |
| Market Cap | $202.66M |
| P/E Ratio | -0.13 |
| EPS | $-34.67 |
| Dividend Yield | 0.00% |
| 52-Week High | $12.46 |
| 52-Week Low | $1.15 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-293.42M |
| Gross Margin | 0.00% |
1 analysts cover NERV: 0 strong buy, 0 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $7.00.